Literature DB >> 31847690

Progressive Histopathological Damage Occurring Up to One Year after Experimental Traumatic Brain Injury Is Associated with Cognitive Decline and Depression-Like Behavior.

Xiang Mao1,2, Nicole A Terpolilli1,2,3, Antonia Wehn1,2, Shiqi Cheng1,2, Farida Hellal1,2, Baiyun Liu4, Burcu Seker1,2, Nikolaus Plesnila1,2.   

Abstract

Increasing clinical and experimental evidence suggests that traumatic brain injury (TBI) is associated with progressive histopathological damage. The aim of the current study was to characterize the time course of motor function, memory performance, and depression-like behavior up to 1 year after experimental TBI, and to correlate these changes to histopathological outcome. Male C57BL/6N mice underwent controlled cortical impact (CCI) or sham operation, and histopathological outcome was evaluated 15 min, 24 h, 1 week, or 1, 3, 6, or 12 months thereafter (n = 12 animals per time point). Motor function, depression-like behavior, and memory function were evaluated concomitantly, and magnetic resonance imaging (MRI) was repeatedly performed. Naïve mice (n = 12) served as an unhandled control group. Injury volume almost doubled within 1 year after CCI (p = 0.008) and the ipsilateral hemisphere became increasingly atrophic (p < 0.0001). Progressive tissue loss was observed in the corpus callosum (p = 0.007) and the hippocampus (p = 0.004) together with hydrocephalus formation (p < 0.0001). Motor function recovered partially after TBI, but 6 months after injury progressive depression-like behavior (p < 0.0001) and loss of memory function (p < 0.0001) were observed. The present study demonstrates that delayed histopathological damage that occurs over months after brain injury is followed by progressive depression and memory loss, changes also observed after TBI in humans. Hence, experimental TBI models in mice replicate long-term sequelae of brain injury such as post-traumatic dementia and depression.

Entities:  

Keywords:  CCI; TBI; cognitive function; degeneration; head trauma

Year:  2020        PMID: 31847690     DOI: 10.1089/neu.2019.6510

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  9 in total

1.  Astaxanthin provides neuroprotection in an experimental model of traumatic brain injury via the Nrf2/HO-1 pathway.

Authors:  Fei Gao; Xiao Wu; Xiang Mao; Fei Niu; Bin Zhang; Jinqian Dong; Baiyun Liu
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

2.  Analyzing the Role of the P2X7 Receptor in Epilepsy.

Authors:  Mariana Alves; Laura de Diego-Garcia; Tobias Engel
Journal:  Methods Mol Biol       Date:  2022

3.  Antioxidant thioether core-crosslinked nanoparticles prevent the bilateral spread of secondary injury to protect spatial learning and memory in a controlled cortical impact mouse model of traumatic brain injury.

Authors:  Aria W Tarudji; Connor C Gee; Sarah M Romereim; Anthony J Convertine; Forrest M Kievit
Journal:  Biomaterials       Date:  2021-03-22       Impact factor: 12.479

Review 4.  Progenitor cell therapy for acquired pediatric nervous system injury: Traumatic brain injury and acquired sensorineural hearing loss.

Authors:  James E Baumgartner; Linda S Baumgartner; Michael E Baumgartner; Ernest J Moore; Steven A Messina; Michael D Seidman; David R Shook
Journal:  Stem Cells Transl Med       Date:  2020-10-09       Impact factor: 6.940

5.  New Mechanistic Insights, Novel Treatment Paradigms, and Clinical Progress in Cerebrovascular Diseases.

Authors:  Johannes Boltze; Jaroslaw A Aronowski; Jerome Badaut; Marion S Buckwalter; Mateo Caleo; Michael Chopp; Kunjan R Dave; Nadine Didwischus; Rick M Dijkhuizen; Thorsten R Doeppner; Jens P Dreier; Karim Fouad; Mathias Gelderblom; Karen Gertz; Dominika Golubczyk; Barbara A Gregson; Edith Hamel; Daniel F Hanley; Wolfgang Härtig; Friedhelm C Hummel; Maulana Ikhsan; Miroslaw Janowski; Jukka Jolkkonen; Saravanan S Karuppagounder; Richard F Keep; Inga K Koerte; Zaal Kokaia; Peiying Li; Fudong Liu; Ignacio Lizasoain; Peter Ludewig; Gerlinde A S Metz; Axel Montagne; Andre Obenaus; Alex Palumbo; Monica Pearl; Miguel Perez-Pinzon; Anna M Planas; Nikolaus Plesnila; Ami P Raval; Maria A Rueger; Lauren H Sansing; Farida Sohrabji; Charlotte J Stagg; R Anne Stetler; Ann M Stowe; Dandan Sun; Akihiko Taguchi; Mickael Tanter; Sabine U Vay; Raghu Vemuganti; Denis Vivien; Piotr Walczak; Jian Wang; Ye Xiong; Marietta Zille
Journal:  Front Aging Neurosci       Date:  2021-01-28       Impact factor: 5.750

Review 6.  Chronic traumatic encephalopathy-a blueprint for the bridge between neurological and psychiatric disorders.

Authors:  Onder Albayram; Sait Albayram; Rebekkah Mannix
Journal:  Transl Psychiatry       Date:  2020-12-08       Impact factor: 6.222

7.  Focal lesion size poorly correlates with motor function after experimental traumatic brain injury in mice.

Authors:  Johannes Walter; Jannis Mende; Samuel Hutagalung; Martin Grutza; Alexander Younsi; Guoli Zheng; Andreas W Unterberg; Klaus Zweckberger
Journal:  PLoS One       Date:  2022-03-16       Impact factor: 3.240

8.  Moderate traumatic brain injury triggers long-term risks for the development of peripheral pain sensitivity and depressive-like behavior in mice.

Authors:  Gundega Stelfa; Baiba Svalbe; Edijs Vavers; Ilmars Duritis; Maija Dambrova; Liga Zvejniece
Journal:  Front Neurol       Date:  2022-09-20       Impact factor: 4.086

9.  Influence of Organic Solvents on Secondary Brain Damage after Experimental Traumatic Brain Injury.

Authors:  Johannes Walter; Julian Schwarting; Nikolaus Plesnila; Nicole A Terpolilli
Journal:  Neurotrauma Rep       Date:  2020-11-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.